Moderna, Inc. is a leading pharmaceutical company based in the United States that specializes in mRNA technology. Known for its groundbreaking COVID-19 vaccine, Moderna has a low ESG risk rating score of 19.6. The company, founded in 2010, has since expanded its portfolio to include 39 mRNA development candidates in various clinical trials. With a focus on therapeutic areas such as infectious diseases, oncology, cardiovascular disease, and rare genetic diseases, Moderna continues to innovate in the field of biotechnology.